Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Biotech
Analysts unshaken by patient death in BMS lung fibrosis trial
Analysts were quick to dismiss concerns that the liver toxicity seen with BMS' admilparant spell larger trouble for the LPA1 drug class.
Darren Incorvaia
Oct 1, 2026 10:22am
Boehringer, Envisagenics ink $1B multi-target oncology collab
Sep 22, 2026 8:00am
BMS dumps $100M degrader-antibody conjugate over ph. 1 data
Sep 18, 2026 3:41am
BMS’ pivotal CAR-T multiple myeloma trial hits primary endpoint
Sep 8, 2026 9:11am
Novartis halts autoimmune CAR-T trials after 3 deaths
Aug 31, 2026 6:25pm
Chai tees up BMS AI antibody discovery collab
Aug 20, 2026 10:55am
